Microneedle Eye Patch OEM

OEM overview

Private-label dissolvable microneedle eye patches with custom formula, shape and packaging options. Each program is reviewed for cosmetic category, technical feasibility, target-market rules and manufacturability before samples begin.

Microneedle Eye Patch OEM development and private label formats

Formula and active options

Potential directions include hyaluronic acid, caffeine, acetyl tetrapeptide-5 and peptide concepts. Final composition, active level, compatibility and claims depend on the agreed specification, stability strategy and destination market.

Cosmetic positioning

Programs may be positioned for hydration and temporary improvement in the appearance of fine lines or puffiness. We avoid medical or drug claims unless the customer establishes a separate, appropriately authorized development pathway.

Customization options

Formula
Adapt an existing platform or develop a project-specific cosmetic concept.

Patch format
Under-eye, outer-eye and ergonomic custom contours.

Microneedle array
Height, density, geometry and array layout subject to feasibility.

Packaging
Barrier pouch, carton, insert, label and artwork coordination.

OEM / private-label workflow

Submit product brief, target market, volume and timing.
Confirm technical assumptions, sample scope and commercial pathway.
Develop or adapt formula and patch geometry.
Evaluate samples against agreed appearance, handling and dissolution criteria.
Align packaging, pilot plan, specifications and production documents.

Important: Ingredient acceptance, product classification, claims, safety substantiation and market authorization vary by jurisdiction. Current facility and product documentation should be reviewed during supplier qualification.

HYTANBIO · CHANGZHOU BASE

Eye-patch array configurations

R&D concepts & configuration references. The supplied portfolio defines starting points for feasibility review, not approved finished products or validated consumer instructions. Nominal needle height is not penetration depth. Formula identity, loading, tolerability, labeling, availability and market classification must be confirmed for the specific project.

R&D concept & configuration reference

Standard eye patch

Array material: Hyaluronic acid (HA)
Nominal needle height: 300–1,000 µm
Needles per patch: 350
Customization: Size and color

Separate three-grade HA eye-care profile

Ingredient reference: Hyaluronic acid in three molecular-weight grades, plant-derived salicin and niacinamide

Catalogue fine-line care, skin firmness and the appearance of eye bags and dark circles; finished-product evidence is required

Portfolio pp. 12, 16

R&D concept & configuration reference

Partial-coverage eye patch

Array material: Hyaluronic acid (HA)
Nominal needle height: 300–1,000 µm
Needles per patch: 350
Customization: Size and color

Portfolio pp. 12

Compare the full portfolio →

HYTANBIO · CHANGZHOU BASE

Build the pair, backing and color presentation

Tray formats: 12 × 8 cm / 9 × 9 cm
Foil pouch: 11 × 16 cm
Illustrated pack: 1 pair
Backing options: PE / PU / TPU / hydrocolloid
Colors: Clear, yellow, purple, orange, blue, pink and custom colors
Tray, size and dimensions: Customizable

The illustrated presentation lists OEM / ODM and complimentary samples. Confirm the actual sample configuration, availability, shipping costs and current terms with the project team.

Eye-patch presentation and color options · Portfolio reference

Request a Custom Formula

Direct answers for OEM buyers

Questions buyers ask before the next step

The following answers convert this page into a decision-ready reference rather than a general marketing summary. Each answer states the conclusion first and then names the variables that can change it. Numerical values such as MOQ, lead time, active content, dimensions, shelf life and price are not presented as universal facts when they depend on an unapproved project specification. This makes the page easier for both human buyers and AI systems to quote accurately: confirmed company or process information remains separate from product-specific assumptions, while cosmetic, medical and jurisdictional boundaries stay visible. For a live project, use these answers to prepare the brief and request the supporting specification, test or contractual record. Mark unresolved inputs as open actions with an owner and due date, then update the controlled project version after evidence is reviewed.

Is Microneedle Eye Patch OEM a ready-stock product?

This page describes a potential custom cosmetic development direction, not guaranteed ready inventory. Formula, active level, array geometry, backing, packaging, MOQ, lead time, evidence and target-market acceptability must be confirmed for the buyer’s approved brief.

Which specifications should be confirmed before sampling?

Confirm ingredient identity and target content basis, matrix and patch dimensions, needle geometry, application area, backing and pouch system, appearance and handling criteria, dissolution method, storage conditions, desired shelf life and claims direction. Record the sample version so feedback is traceable.

Which claims can the finished patch use?

Claims must remain consistent with the product category and be supported for the finished product as presented and used. Ingredient studies do not automatically substantiate the patch. Avoid treatment, disease, structural or drug-delivery claims unless a separate qualified regulatory pathway has been established.

Content review: Last reviewed October 15, 2026. Material changes to formula, claims, manufacturing scope or target market require a fresh review.